Cancer Care Associates (New South Wales)
Hospitals/Inpatient Services
Cancer Care Associates (New South Wales) valuation and funding history | Last updated: December 20, 2021 | 1 funding rounds
Current Valuation
N/A
As of December 20, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO
$71.3M
Last Funding
Dec 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 20, 2021 | Buyout/LBO | $71.3M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Cancer Care Associates (New South Wales) is currently valued at N/A as of December 20, 2021.
Explore More Data
Detailed analysis for Cancer Care Associates (New South Wales)
What is Cancer Care Associates (New South Wales) Worth in 2026?
Cancer Care Associates (New South Wales) is a leading private company in the Hospitals/Inpatient Services sector. Track Cancer Care Associates (New South Wales)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Cancer Care Associates (New South Wales) Valuation is Determined
Private company valuations like Cancer Care Associates (New South Wales)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.